Southeast Asia Pharmaceutical Forum
About This Event
The combined share of prescription drug spending in the US and Europe will shrink from 61% in 2005 to 44% by 2015. At the same time, spending in the emerging markets will grow from 12% in 2005 to 28% by 2015. - IMS Health report, 2011
With prolonged global economic crises and slowdown in the West, companies are increasingly looking towards the emerging markets. With a rapidly expanding, affluent (and ageing) population demanding greater access to affordable safe medicines, coupled with rising spending power, Southeast Asia presents the next growth area.
While China and India have grabbed the attention of MNCs and domestics vying for a slice of those markets, competition has intensified, resulting in some cases with questionable quality. In contrast, Southeast Asian countries including Vietnam, Thailand, Philippines and Indonesia present strong domestic growth, with potential for development as these pharmaceutical industries are still in its infancy.
IBC’s Southeast Asia Pharmaceutical Forum is the ONLY conference enabling you to explore the growth, opportunities and challenges of the next wave of pharmerging markets in the region. Beyond the BRIC economies, find out how to strategically position your products, launch successfully and tap the potential in Asia. Southeast Asia Pharmaceutical Forum brings together country heads and speakers specializing in the field, to bring the first-ever extensive, in-depth view of this region.
Key Themes and Topics Addressed
IMS Health will share latest research insights on Asia’s pharmerging landscape
Financing and micro-financing available in Asia
Actavis and Pfizer Indonesia on how to tap into Indonesia’s middle class and navigating new healthcare policies
What is the state of Southeast Asia’s clinical developments?
Protecting your innovations protected in the IP courts
Find new revenue streams and leverage strengths in traditional small molecules to biologics
How are innovators in Thailand taking on the rampant generic presence?
Learn from Getz Pharma the key to marketing in Vietnam
Pricing and reimbursement and evaluating investments into the Philippines
How will the next wave of pharmerging Asia shape up in pharma’s Asian strategies?